23.97
전일 마감가:
$26.44
열려 있는:
$26.21
하루 거래량:
2.90M
Relative Volume:
3.45
시가총액:
$1.19B
수익:
$290.38M
순이익/손실:
$-21.03M
주가수익비율:
-55.82
EPS:
-0.4294
순현금흐름:
$-54.99M
1주 성능:
-13.71%
1개월 성능:
-17.69%
6개월 성능:
+14.31%
1년 성능:
+38.08%
Staar Surgical Co Stock (STAA) Company Profile
명칭
Staar Surgical Co
전화
(626) 303-7902
주소
1911 WALKER AVE, MONROVIA, CA
Compare STAA vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
STAA
Staar Surgical Co
|
23.97 | 1.32B | 290.38M | -21.03M | -54.99M | -0.4294 |
|
ISRG
Intuitive Surgical Inc
|
353.17 | 122.33B | 11.03B | 3.16B | 2.83B | 8.7254 |
|
BDX
Becton Dickinson Co
|
154.48 | 43.58B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
70.04 | 34.27B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
38.88 | 33.65B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
198.61 | 28.86B | 5.54B | 1.52B | 1.74B | 10.37 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2026-02-03 | 개시 | Wedbush | Neutral |
| 2026-01-16 | 재개 | Morgan Stanley | Underweight |
| 2025-04-21 | 개시 | Wells Fargo | Equal Weight |
| 2025-02-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-02-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-02-12 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2025-02-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-03-11 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-05 | 다운그레이드 | Needham | Buy → Hold |
| 2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-09-15 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | 개시 | Piper Sandler | Neutral |
| 2023-02-06 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-12-28 | 재확인 | BTIG Research | Buy |
| 2022-12-08 | 개시 | Stifel | Hold |
| 2022-11-07 | 업그레이드 | Sidoti | Neutral → Buy |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-28 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-07-09 | 개시 | Oppenheimer | Perform |
| 2021-01-19 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-10-26 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-08-31 | 업그레이드 | Sidoti | Neutral → Buy |
| 2020-08-06 | 재확인 | The Benchmark Company | Buy |
| 2020-07-06 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2020-06-24 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-06-15 | 개시 | Jefferies | Buy |
| 2019-12-04 | 개시 | BTIG Research | Buy |
| 2018-09-24 | 재확인 | The Benchmark Company | Buy |
| 2018-08-06 | 재개 | The Benchmark Company | Buy |
| 2017-11-20 | 재확인 | The Benchmark Company | Buy |
| 2017-08-14 | 재확인 | The Benchmark Company | Buy |
| 2017-03-03 | 재확인 | The Benchmark Company | Buy |
| 2016-05-18 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2013-09-10 | 재개 | The Benchmark Company | Buy |
| 2013-02-28 | 재확인 | The Benchmark Company | Buy |
| 2012-11-01 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | 개시 | Northland Securities | Outperform |
| 2011-10-25 | 재확인 | The Benchmark Company | Buy |
| 2010-10-12 | 개시 | Morgan Joseph | Buy |
| 2010-05-11 | 개시 | Benchmark | Buy |
모두보기
Staar Surgical Co 주식(STAA)의 최신 뉴스
STAAR Surgical Shows Strong Preliminary Q2 Results, With Double-Digit Sales Growth in Americas - VisionMonday.com
STAAR Surgical (STAA) Stock Could Be 12% Undervalued On Q2 Sales Recovery - simplywall.st
STAAR Surgical (STAA) Reports Strong Q2 Sales but Shares Drop - GuruFocus
STAAR Surgical (STAA) Shares Drop Despite Strong Q2 Revenue - GuruFocus
A Look at Staar Surgical Co (STAA) After 8.8% Decline -- GF Value $32.05 vs Price $26.44 - GuruFocus
Medical Device Stocks Decline Amid Insurance Changes - Intellectia AI
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know - Yahoo! Finance Canada
STAAR Surgical (STAA) Faces Significant Drop Despite Strong Q2 S - GuruFocus
STAA Stock On Track For Its Fourth Straight Session Of Gains – This Analyst Would Rather Be Early Than Late On Staar’s Growth Story - Stocktwits
Why is STAAR Surgical stock sliding today? By Investing.com - Investing.com South Africa
Caution Lingers for STAAR Surgical Amid Middle East Geopolitical Tensions - Benzinga
Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session - Benzinga
Why is STAAR Surgical stock sliding today? - Investing.com UK
STAAR Surgical Q2 net sales more than double on growth in China, Asia-Pacific, Americas - Bitget
Staar Surgical Dips 8.4% After Hours on Early Q2 Results - Orange County Business Journal
Canaccord reiterates STAAR Surgical stock rating on Q2 revenue beat By Investing.com - Investing.com Canada
STAAR Surgical Q2 sales exceed $90 million led by Asia growth - scanx.trade
Staar Surgical (STAA) Reports Strong Q2 Sales Amid Regional Chal - GuruFocus
STAAR Surgical reports Q2 sales to exceed $90 million - Investing.com
STAAR Surgical reports Q2 sales to exceed $90 million By Investing.com - Investing.com UK
STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026 - Business Wire
STAA Reiterated by Wedbush -- Price Target Maintained at $40 - GuruFocus
Analysts Are Bullish on Top Healthcare Stocks: Staar Surgical (STAA), Definium Therapeutics (DFTX) - The Globe and Mail
STAAR Surgical Co highlights its vision correction technology as investors weigh long-term growth - Ad-hoc-news.de
3 Reasons to Avoid STAA and 1 Stock to Buy Instead - Yahoo Finance
STAAR SURGICAL CO (STAA) Stock Chart - ChartMill
STAAR Surgical clears a key FDA milestone, shares in the medical device sector spotlight - ad-hoc-news.de
STAAR Surgical (STAA) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Form 4 STAAR Surgical Company For: 23 June By Investing.com - Investing.com Australia
5 must-read analyst questions from STAAR Surgical’s Q1 earnings call - MSN
Director of STAAR Surgical (NASDAQ: STAA) receives grant of 11,145 stock options - Stock Titan
Form 4 STAAR Surgical Company For: 22 June By Investing.com - Investing.com Nigeria
STAAR Surgical (STAA) director awarded 11,145 stock options at $29.12 strike - Stock Titan
Director Neal Bradsher granted 11,145 STAAR Surgical (STAA) stock options - Stock Titan
STAAR Surgical (NASDAQ: STAA) director adds shares and options in equity grants - Stock Titan
STAAR Surgical (STAA) adds 3.9M plan shares, elects board and ratifies BDO - Stock Titan
[Form 4] STAAR SURGICAL CO Insider Trading Activity - Stock Titan
STAAR Surgical (STAA) director Jiang Wei exercises RSUs and receives new grant - Stock Titan
STAAR Surgical (STAA) director awarded RSUs and exercises prior units - Stock Titan
STAAR Surgical StockAnalyst views and long-term growth drivers - Ad-hoc-news.de
STAAR Surgical Co (STAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
STAAR Surgical Co (STAA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
STAAR Surgical Co (STAA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
STAAR Surgical Co (STAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
STAAR Surgical Co (STAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
STAAR Surgical Co (STAA) Institutional Confidence - TradingKey
STAAR Surgical Co (STAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
STAAR Surgical Co (STAA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
STAAR Surgical Co (STAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Is STAAR Surgical Regaining Market Momentum? - Kalkine Media
STAAR Surgical (STAA) Stock Could Be 4.4% Undervalued Despite Its Rich P S Multiple - simplywall.st
Staar Surgical Co (STAA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Staar Surgical Co 주식 (STAA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SILVERMAN LOU | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
11,158 |
| Jiang Wei | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
77,127 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 14 '26 |
Option Exercise |
0.00 |
29,325 |
0 |
63,588 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 12 '26 |
Option Exercise |
0.00 |
8,175 |
0 |
34,263 |
| Michna Magda | Chief Development Officer |
Mar 14 '26 |
Option Exercise |
0.00 |
17,595 |
0 |
36,001 |
| Michna Magda | Chief Development Officer |
Mar 12 '26 |
Option Exercise |
0.00 |
6,178 |
0 |
20,622 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 13 '26 |
Buy |
18.61 |
316,017 |
5,882,656 |
16,123,842 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 12 '26 |
Buy |
18.12 |
299,432 |
5,424,330 |
15,807,825 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 11 '26 |
Buy |
17.52 |
54,764 |
959,558 |
15,508,393 |
| Jiang Wei | Director |
Jan 12 '26 |
Option Exercise |
0.00 |
20,967 |
0 |
66,444 |
자본화:
|
볼륨(24시간):